Posted on Tue, Jul. 22, 2008
Encorium Group Inc., Wayne, which designs and manages clinical trials and patient registries for pharmaceutical and biotechnology companies, said today it won contracts worth $5 million from several multinational and smaller biopharmaceutical companies.
The companies awarding the contracts were not identified, but Encorium said the therapeutic areas included are cardiovascular diseases, oncology, diabetes and infectious diseases. Both in North America and Europe, Encorium will provide medical and scientific consulting, data management, regulatory affairs, project management, field monitoring, and medical monitoring and writing services.
Revenue from the contracts is expected to begin in the third quarter, with some of it based on when contract services are completed.
Encorium has announced about $10 million of new contracts during the last week, said Kenneth M. Borow, Encorium's president and chief medical and strategic development officer.
today's poll
email this
print this
reprint or license this
